Iodine-131 Treatment of Thyroid Papillary Carcinoma in Patients Undergoing Dialysis for Chronic Renal Failure: A Dosimetric Method
- 1 November 2001
- journal article
- case report
- Published by SAGE Publications in Thyroid®
- Vol. 11 (11) , 1031-1034
Abstract
Until recently, the therapeutic protocol widely accepted for ablation of the thyroid remnant and for metastases of thyroid papillary carcinoma was the administration of 131I after surgery. However, at present, some data question the usefulness of such treatment in patients considered low risk. The treatment with radioiodine in patients suffering from end-stage renal disease (ESRD) undergoing hemodialysis requires controlled dosages and individualized administration guidelines. The need to include these patients on the waiting list for a renal transplantation, once they have overcome the disease, and the higher prevalence of thyroid carcinoma in ESRD patients makes this an increasingly significant problem. The cases reported in the literature are few and the therapeutic models followed are very difficult. In this paper we propose a therapeutic model that provides the highest thyroid ablative dosage, minimizing radiation exposure to the rest of the organs. The main difference between our protocol and that already described is the performance of daily hemodialysis during the first 5 days of treatment, as well as the administration of a dose of 131I equivalent to that administered to patients who show normal renal function.Keywords
This publication has 8 references indexed in Scilit:
- Radioiodine Treatment of Thyroid Carcinoma in Patients on Maintenance HemodialysisThyroid®, 1996
- Thyroid hormone metabolism and thyroid diseases in chronic renal failureEndocrine Reviews, 1996
- Radioiodine Therapy for Thyroid CancerEndocrinology and Metabolism Clinics of North America, 1995
- Management of Thyroid Papillary Carcinoma With Radioiodine in a Patient With End Stage Renal Disease on HemodialysisClinical Nuclear Medicine, 1994
- Thyroid carcinoma in patients with secondary hyperparathyroidismJournal of Surgical Oncology, 1992
- 131I treatment of thyroid papillary carcinoma in a patient with renal failureCancer, 1990
- Iodine Retention and Thyroid Dysfunction in Patients on Hemodialysis and Continuous Ambulatory Peritoneal DialysisAmerican Journal of Kidney Diseases, 1986
- Iodine 131 ablation therapy for a patient on maintenance haemodialysisBritish Journal of Radiology, 1981